In the week of August 17, 2026, 33 holders filed a new Schedule 13D and 65 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Liu Ming Hui's 94.8% of Enersyn Global Inc. (Schedule 13D, August 17, 2026).
New 13D33
New 13G65
Stated intents0
The week of 2026-08-17, 33 holders filed a new Schedule 13D and 65 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-08-17 | Enersyn Global Inc. | Liu Ming Hui | 94.8% | SCHEDULE 13D |
| 2026-08-18 | Suja Life, Inc. | Paine Schwartz Food Chain Fund V GP, Ltd. | 62.77% | SCHEDULE 13D |
| 2026-08-19 | Profusa, Inc. | NorthView Sponsor I, LLC | 49.9% | SCHEDULE 13D |
| 2026-08-18 | Advasa Holdings, Inc. | Kosugi Asamitsu | 47.76% | SCHEDULE 13D |
| 2026-08-21 | Air Water Ventures Ltd | Inflection Point Asset Management LLC | 40.5% | SCHEDULE 13D |
| 2026-08-20 | Dogness (International) Corporation | Fuxing Yang | 35.67% | SCHEDULE 13D |
| 2026-08-19 | OceanLight Acquisition Corporation | OceanLight Capital Sponsor Ltd | 33.53% | SCHEDULE 13D |
| 2026-08-19 | Futurewave Acquisition Corp | Futurewave Capital Solutions Ltd | 30.8% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | Steven Kenneth Hudson | 27.82% | SCHEDULE 13D |
| 2026-08-18 | Advasa Holdings, Inc. | Tatsuya Akimoto | 27.81% | SCHEDULE 13D |
| 2026-08-18 | SunScout Holding Ltd | Cywinski Friedrich Edwin | 27.5% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | Andrew Rechtschaffen | 26.85% | SCHEDULE 13D |
| 2026-08-18 | Katapult Holdings, Inc. | BasePoint Group Inc. | 26.8% | SCHEDULE 13D |
| 2026-08-19 | Pelican Acquisition II Corp | Pelican II Capital Solutions Ltd | 26.36% | SCHEDULE 13D |
| 2026-08-18 | SunScout Holding Ltd | Cywinski Marc | 23.2% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | PAC Sponsor, LLC | 23% | SCHEDULE 13D |
| 2026-08-18 | Katapult Holdings, Inc. | William Allan Jones | 21.8% | SCHEDULE 13D |
| 2026-08-17 | Jewett Cameron Trading Co Ltd | Kotarba Partners Fund I, LP | 20.98% | SCHEDULE 13D |
| 2026-08-18 | Braveheart Bio, Inc. | Orbimed Advisors LLC | 17.2% | SCHEDULE 13D |
| 2026-08-17 | Alumis Inc | Foresite Capital Fund VI LP | 14.5% | SCHEDULE 13D |
| 2026-08-17 | Latigo Biotherapeutics, Inc. | Foresite Capital Fund VI LP | 14.5% | SCHEDULE 13D |
| 2026-08-20 | Addentax Group Corp. | Hong Zhiwang | 10.7% | SCHEDULE 13D |
| 2026-08-17 | Femasys Inc. | Nantahala Capital Partners Limited Partnership | 9.99% | SCHEDULE 13D |
| 2026-08-20 | Super League Enterprise, Inc. | Evo Fund | 9.9% | SCHEDULE 13D |
| 2026-08-20 | Group 1 Automotive Inc | Conifer Management, L.L.C. | 9.7% | SCHEDULE 13D |
| 2026-08-18 | HeartSciences Inc. | Digital Currency Group, Inc. | 9.4% | SCHEDULE 13D |
| 2026-08-18 | BlossomHill Therapeutics, Inc. | Orbimed Advisors LLC | 8.9% | SCHEDULE 13D |
| 2026-08-21 | Jin Medical International Ltd. | Wang Erqi | 6.77% | SCHEDULE 13D |
| 2026-08-21 | Cue Biopharma, Inc. | Shao-Lee Lin | 6.2% | SCHEDULE 13D |
| 2026-08-20 | Hepion Pharmaceuticals, Inc. | Gary Stetz | 5.7% | SCHEDULE 13D |
| 2026-08-20 | Hepion Pharmaceuticals, Inc. | Sireesh Appajosyula | 5.7% | SCHEDULE 13D |
| 2026-08-21 | Immersion Corp | Singer Eric | 5.5% | SCHEDULE 13D |
| 2026-08-18 | Conexeu Sciences Inc. | Jeffrey Sharpe | 5.4% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-08-19 | Fort Technology Inc | Nexera Technologies Ltd | 72.53% | SCHEDULE 13G |
| 2026-08-18 | Gores Holdings XI, Inc. | Gores Sponsor XI LLC | 20.3% | SCHEDULE 13G |
| 2026-08-19 | DSC Holdings Ltd. | Ant Group Co., Ltd. | 18.4% | SCHEDULE 13G |
| 2026-08-19 | iOThree Limited | Jun Li | 16.3% | SCHEDULE 13G |
| 2026-08-17 | Aeon Acquisition I Corp. | Polar Asset Management Partners Inc. | 13.6% | SCHEDULE 13G |
| 2026-08-21 | AEON Biopharma, Inc. | Timothy P. Lynch | 13% | SCHEDULE 13G |
| 2026-08-20 | Advanced Biomed Inc. | Pau Hung To | 12.75% | SCHEDULE 13G |
| 2026-08-17 | Kartoon Studios Inc | Clear Street Derivatives LLC | 12% | SCHEDULE 13G |
| 2026-08-20 | Addentax Group Corp. | Hong Zhihao | 11.88% | SCHEDULE 13G |
| 2026-08-20 | Addentax Group Corp. | Pinnacle Partners Inc. | 11.88% | SCHEDULE 13G |
| 2026-08-20 | Swarmer, Inc | RG.AI Technologies, Inc. | 10.98% | SCHEDULE 13G |
| 2026-08-18 | Jin Medical International Ltd. | Novastralist Horizon Ltd. | 10.46% | SCHEDULE 13G |
| 2026-08-18 | Addentax Group Corp. | Seah Chia Yee | 10.3% | SCHEDULE 13G |
| 2026-08-17 | Borr Drilling Limited | cobas asset management, sgiic, s.a. | 10.2% | SCHEDULE 13G |
| 2026-08-17 | Achieve Life Sciences, Inc. | Logos Global Management LP | 9.99% | SCHEDULE 13G |
| 2026-08-21 | Catheter Precision, Inc. | C/M Capital Partners, LP | 9.99% | SCHEDULE 13G |
| 2026-08-20 | 22nd Century Group | Joseph Reda | 9.97% | SCHEDULE 13G |
| 2026-08-17 | Jasper Therapeutics, Inc. | Velan Capital Investment Management LP | 9.9% | SCHEDULE 13G |
| 2026-08-18 | Edgemode, Inc. | Clearthink Capital Partners, LLC | 9.9% | SCHEDULE 13G |
| 2026-08-19 | Outlook Therapeutics, Inc. | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2026-08-20 | 22nd Century Group | Schechter Jonathan | 9.9% | SCHEDULE 13G |
| 2026-08-17 | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 9.8% | SCHEDULE 13G |
| 2026-08-21 | Nano Dimension Ltd. | Tang Capital Management, LLC | 9.1% | SCHEDULE 13G |
| 2026-08-19 | iOThree Limited | YR Sea Group Pte. Ltd. | 8.72% | SCHEDULE 13G |
| 2026-08-17 | Thunder Bridge Capital Partners V, Ltd. | MMCAP International Inc. SPC | 8.5% | SCHEDULE 13G |
| 2026-08-20 | GoPro, Inc. | Fischbach Mark Edward | 8.5% | SCHEDULE 13G |
| 2026-08-17 | Latigo Biotherapeutics, Inc. | RA Capital Management, L.P. | 8.4% | SCHEDULE 13G |
| 2026-08-19 | Biovie Inc. | Alta Partners LLC | 8.4% | SCHEDULE 13G |
| 2026-08-21 | iOThree Limited | PT Vox Inovasi Nusantara | 8.34% | SCHEDULE 13G |
| 2026-08-21 | Royalty Management Holding Corp | First Frontier Capital LLC | 8.2% | SCHEDULE 13G |
| 2026-08-20 | Mayfair Gold Corp. | Oaktree Capital Management, L.P. | 8.19% | SCHEDULE 13G |
| 2026-08-18 | Advasa Holdings, Inc. | Taiji Ito | 8.13% | SCHEDULE 13G |
| 2026-08-18 | Conexeu Sciences Inc. | David Bogart | 8.1% | SCHEDULE 13G |
| 2026-08-18 | PSB Financial, Inc. | PSB Financial, Inc. Employee Stock Ownership Plan Trust | 8% | SCHEDULE 13G |
| 2026-08-19 | C3is Inc. | Jane Street Group, LLC | 7.2% | SCHEDULE 13G |
| 2026-08-20 | Charter Communications Inc | Ronald A. Duncan | 6.6% | SCHEDULE 13G |
| 2026-08-20 | Thunder Bridge Capital Partners V, Ltd. | Linden Capital L.P. | 6.3% | SCHEDULE 13G |
| 2026-08-19 | Tidal Trust II | Vencl William John Jr | 6.2% | SCHEDULE 13G |
| 2026-08-20 | Gmr Solutions Inc | North Peak Capital Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-08-21 | Lincoln National Corp | BlackRock, Inc. | 6.2% | SCHEDULE 13G |
| 2026-08-19 | RxSight, Inc. | Point72 Asset Management, L.P. | 6% | SCHEDULE 13G |
| 2026-08-21 | Royalty Management Holding Corp | White River Ventures LLC | 6% | SCHEDULE 13G |
| 2026-08-19 | Stereotaxis, Inc. | Daniel Louis Kaufman | 5.9% | SCHEDULE 13G |
| 2026-08-21 | Micropolis AI Robotics | Alexander Rugaev | 5.9% | SCHEDULE 13G |
| 2026-08-18 | Tenax Therapeutics Inc | Millennium Management LLC | 5.8% | SCHEDULE 13G |
| 2026-08-18 | Processa Pharmaceuticals, Inc. | Soleus Capital Master Fund, L.P. | 5.8% | SCHEDULE 13G |
| 2026-08-19 | Grocery Outlet Holding Corp. | Pertento Partners LLP | 5.6% | SCHEDULE 13G |
| 2026-08-19 | Vanda Pharmaceuticals Inc. | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-08-17 | BlossomHill Therapeutics, Inc. | Vivo Innovation Fund II Holdings, L.P. | 5.5% | SCHEDULE 13G |
| 2026-08-19 | T1 Energy Inc. | Millennium Management LLC | 5.5% | SCHEDULE 13G |
| 2026-08-20 | MapLight Therapeutics, Inc. | Nan Fung Group Holdings Limited | 5.5% | SCHEDULE 13G |
| 2026-08-17 | KKR Real Estate Finance Trust Inc. | Terra Capital Partners, LLC | 5.4% | SCHEDULE 13G |
| 2026-08-21 | CDT Equity Inc. | Primary Development Fund (Cayman) SPC | 5.3% | SCHEDULE 13G |
| 2026-08-20 | Black Stone Minerals, L.P. | Morgan Stanley | 5.2% | SCHEDULE 13G |
| 2026-08-19 | AVAX One Technology Ltd. | Saba Capital Management, L.P. | 5.11% | SCHEDULE 13G |
| 2026-08-17 | InflaRx N.V. | Commodore Capital LP | 5.1% | SCHEDULE 13G |
| 2026-08-18 | Cellebrite DI Ltd. | Voss Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-08-20 | Rank One Computing Corp | Laurence W. Lytton | 5.1% | SCHEDULE 13G |
| 2026-08-20 | Redwood Trust, Inc. | Bay Pond Investors (Bermuda) L.P. | 5.1% | SCHEDULE 13G |
| 2026-08-21 | CDT Environmental Technology Investment Holdings Ltd | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-08-17 | Hancock Park Corporate Income, Inc. | Orchard First Source Asset Management Holdings, LLC | 5.02% | SCHEDULE 13G |
| 2026-08-17 | Groupon, Inc. | Millennium Management LLC | 5% | SCHEDULE 13G |
| 2026-08-18 | Latigo Biotherapeutics, Inc. | AI Biotechnology LLC | 5% | SCHEDULE 13G |
| 2026-08-20 | Viridian Therapeutics, Inc. | Point72 Asset Management, L.P. | 5% | SCHEDULE 13G |
| 2026-08-21 | Neo-Concept International Group Holdings Ltd | Jane Street Group, LLC | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)98 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.